Abstract:Prions represent a group of proteins with a unique capacity to fold into different conformations. One isoform is rich in beta-pleated sheets and can aggregate into amyloid that may be pathogenic. This abnormal form propagates itself by imposing its confirmation on the homologous normal host cell protein. Pathogenic prions have been shown to cause lethal neurodegenerative diseases in humans and animals. These diseases are sometimes infectious and hence referred to as transmissible spongiform encephalopathies. In the present review, the remarkable evolution of the heterodox prion concept is summarized. The origin of this phenomenon is based on information transfer between homologous proteins, without the involvement of nucleic acid-encoded mechanisms. Historically, kuru and Creutzfeldt-Jakob disease (CJD) were the first infectious prion diseases to be identified in man. It was their relationship to scrapie in sheep and experimental rodents that allowed an unravelling of the particular molecular mechanism that underlie the disease process. Transmission between humans has been documented to have occurred in particular contexts, including ritual cannibalism, iatrogenic transmission because of pituitary gland-derived growth hormone or the use in neurosurgical procedures of dura mater from cadavers, and the temporary use of a prion-contaminated protein-rich feed for cows. The latter caused a major outbreak of bovine spongiform encephalopathy, which spread to man by human consumption of contaminated meat, causing approximately 200 cases of variant CJD. All these epidemics now appear to be over because of measures taken to curtail further spread of prions. Recent studies have shown that the mechanism of protein aggregation may apply to a wider range of diseases in and possibly also outside the brain, some of which are relatively common such as Alzheimer's and Parkinson's diseases. Furthermore, it has become apparent that the phenomenon of prion aggregation may have a wider physiological importance, but a full understanding of this remains to be defined. It may involve maintaining neuronal functions and possibly contributing to the establishment of long-term memory.

Prion Protein Oligomer and Its Neurotoxicity

Using Protein Misfolding Cyclic Amplification Generates a Highly Neurotoxic PrP Dimer Causing Neurodegeneration

Mechanisms of prion-induced toxicity

Protein misfolding cyclic amplification induces the conversion of recombinant prion protein to PrP oligomers causing neuronal apoptosis.

Prions Mediated Neurodegenerative Disorders.

Prion Protein Misfolding, Strains, and Neurotoxicity: An Update from Studies on Mammalian Prions

Prions and protein-folding diseases

Distinct Effects of Mutations on Biophysical Properties of Human Prion Protein Monomers and Oligomers.

Interaction Between Misfolded PrP and the Ubiquitin-Proteasome System in Prion-Mediated Neurodegeneration.

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Recent progress in prion and prion-like protein aggregation.

Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and Its Derivatives

Oligomeropathies, inflammation and prion protein binding

PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Targeting Prion-Like Protein Spreading in Neurodegenerative Diseases

Biophysical Characterization of Oligomerization and Fibrillization of the G131V Pathogenic Mutant of Human Prion Protein.

The Prion Basis of Progressive Neurodegenerative Disorders

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases

Progresses on Prion Proteins

Cytotoxic Amyloid Fibrils From Full-length Human PrPC are Transmissible to Induce The Misfolding of Endogenous PrPC